Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

✍ Scribed by Schneeweiss, A.; Chia, S.; Hickish, T.; Harvey, V.; Eniu, A.; Hegg, R.; Tausch, C.; Seo, J. H.; Tsai, Y.- F.; Ratnayake, J.; McNally, V.; Ross, G.; Cortes, J.

• Book ID: 126062967
• Publisher: Oxford University Press
• Year: 2013
• Tongue: English
• Weight: 251 KB
• Volume: 24
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdt182